Adipose tissue area is a predictive biomarker for the efficacy of pegylated liposomal doxorubicin in platinum‐refractory/resistant ovarian cancer

BACKGROUND: Pegylated liposomal doxorubicin (PLD), an anthracycline agent, is widely used as a treatment option for platinum‐refractory/resistant epithelial ovarian cancer (EOC). Although only a subset of patients with platinum‐refractory/resistant EOC derive benefit from PLD, predictive biomarkers...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Hiroyuki, Fujiwara, Keiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358198/
https://www.ncbi.nlm.nih.gov/pubmed/37184128
http://dx.doi.org/10.1002/cam4.6086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358198/
https://www.ncbi.nlm.nih.gov/pubmed/37184128
http://dx.doi.org/10.1002/cam4.6086

Ejemplares similares